Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Public Plan Using Medicare Rates Would Face Major Push-Back, Insurers Say

Executive Summary

Provider opposition to a public insurance plan basing payments on Medicare rates may be enough to derail the idea of a public option in a health reform package, two leading insurers suggested in recent financial calls

You may also be interested in...



Insurers Remain Skeptical Of Public Plan As Sen. Schumer Rolls Out Proposal

Representatives of the insurance industry and big business remained skeptical about the feasibility and fairness of a public insurance option competing with private plans during a Senate Finance Committee roundtable discussion May 5

Insurers Remain Skeptical Of Public Plan As Sen. Schumer Rolls Out Proposal

Representatives of the insurance industry and big business remained skeptical about the feasibility and fairness of a public insurance option competing with private plans during a Senate Finance Committee roundtable discussion May 5

Incremental Health Reform First: Medco Sees Growing Resistance Around Price Controls

CEO Snow suggests that resistance to proposals authorizing government price controls through a public insurance option could also bring down programs with broad support, such as expanded use of health IT.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel